Logo-apb
Adv Pharm Bull. 2018;8(3): 419-427. doi: 10.15171/apb.2018.049
PMID: 30276138        PMCID: PMC6156478

Research Article

Fabrication and Characterization of Gliclazide Nanocrystals

Nagaraju Ravouru 1 ORCID, Rajeswari Surya Anusha Venna 1, Subhash Chandra Bose Penjuri 2 * ORCID, Saritha Damineni 3 ORCID, Venkata Subbaiah Kotakadi 4, Srikanth Reddy Poreddy 2 ORCID

Cited by CrossRef: 8


1- Reza Pouretedal H, Damiri S, Moslemi J. Re‐Crystallization of HNS‐IV by Optimization of Solvent/Anti‐Solvent Method through Taguchi Analysis Design. Propellants Explo Pyrotec. 2020;45(7):1111 [Crossref]
2- Liw J, Teoh X, Teoh A, Chan S. The Effect of Carrier-Drug Ratios on Dissolution Performances of Poorly Soluble Drug in Crystalline Solid Dispersion System. Journal of Pharmaceutical Sciences. 2022;111(1):95 [Crossref]
3- Youssef J, Boraie N, Ibrahim H, Ismail F, El-Moslemany R. Glibenclamide Nanocrystal-Loaded Bioactive Polymeric Scaffolds for Skin Regeneration: In Vitro Characterization and Preclinical Evaluation. Pharmaceutics. 2021;13(9):1469 [Crossref]
4- Sampathi S, Prajapati S, Junnuthula V, Dyawanapelly S. Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension. Pharmaceutics. 2022;14(9):1947 [Crossref]
5- Bahoor A, Ahmadi R, Heydari M, Bagheri M, Behnamghader A. Synthesis and evaluation of cross-linked gelatin nanoparticles for controlled release of an anti-diabetic drug: Gliclazide. Inorganic Chemistry Communications. 2023;154:110856 [Crossref]
6- Patel H, Pandey N, Patel B, Ranch K, Bodiwala K, Vyas B. Enhancement of in vivo hypoglycemic effect of gliclazide by developing self-microemulsifying pellet dosage form. Futur J Pharm Sci. 2020;6(1) [Crossref]
7- Zheng T, Cui M, Chen H, Wang J, Ye H, Zhang Q, Sun S, Feng Y, Zhang Y, Liu W, Chen R, Li Y, Dong Z. Co-assembled nanocomplexes comprising epigallocatechin gallate and berberine for enhanced antibacterial activity against multidrug resistant Staphylococcus aureus. Biomedicine & Pharmacotherapy. 2023;163:114856 [Crossref]
8- Nasr M, Almawash S, Al Saqr A, Bazeed A, Saber S, Elagamy H. Bioavailability and Antidiabetic Activity of Gliclazide-Loaded Cubosomal Nanoparticles. Pharmaceuticals. 2021;14(8):786 [Crossref]